Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
CBG-MEB · 4 medicines
FDA · 4 medicines
Anvisa · 2 medicines
EMA · 1 medicine
AIFA · 1 medicine
HSA · 1 medicine
TFDA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
4 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| INOVELON 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | Spain | 100 mg | comprimido recubierto con película | Marketed | Eisai Gmbh |
| INOVELON 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | Spain | 200 mg | comprimido recubierto con película | Marketed | Eisai Gmbh |
| INOVELON 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | Spain | 400 mg | comprimido recubierto con película | Marketed | Eisai Gmbh |
| INOVELON 40 mg/ml SUSPENSION ORAL | Spain | 40 mg | suspensión oral | Marketed | Eisai Gmbh |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
